Faid Valegh, Evjen Gry, Tollersrud Ole-Kristian, Michalski Jean-Claude, Morelle Willy
Unité Mixte de Recherche CNRS/USTL 8576, Glycobiologie Structurale et Fonctionnelle, 1FR 118 Bâtiment C9, Université des Sciences et Technologies de Lille 1, 59655 Villeneuve d' Ascq Cedex. France.
Glycobiology. 2006 May;16(5):440-61. doi: 10.1093/glycob/cwj081. Epub 2006 Jan 31.
Lysosomal alpha-mannosidase is a broad specificity exoglycosidase involved in the ordered degradation of glycoproteins. The bovine enzyme is used as an important model for understanding the inborn lysosomal storage disorder alpha-mannosidosis. This enzyme of about 1,000 amino acids consists of five peptide chains, namely a- to e-peptides and contains eight N-glycosylation sites. The N(497) glycosylation site of the c-peptide chain is evolutionary conserved among LAMANs and is very important for the maintenance of the lysosomal stability of the enzyme. In this work, relying on an approach based on mass spectrometric techniques in combination with exoglycosidase digestions and chemical derivatizations, we will report the detailed structures of the N-glycans and their distribution within six of the eight N-glycosylation sites of the bovine glycoprotein. The analysis of the PNGase F-released glycans from the bovine LAMAN revealed that the major structures fall into three classes, namely high-mannose-type (Fuc(0-1)Glc(0-1)Man(4-9)GlcNAc(2)), hybrid-type (Gal(0-1)Man(4-5)GlcNAc(4)), and complex-type (Fuc(0-1)Gal(0-2)Man(3)GlcNAc(3-5)) N-glycans, with core fucosylation and bisecting GlcNAc. To investigate the exact structure of the N-glycans at each glycosylation site, the peptide chains of the bovine LAMAN were separated using SDS-PAGE and in-gel deglycosylation. These experiments revealed that the N(497) and N(930) sites, from the c- and e-peptides, contain only high-mannose-type glycans Glc(0-1)Man(5-9)GlcNAc(2), including the evolutionary conserved Glc(1)Man(9)GlcNAc(2) glycan, and Fuc(0-1)Man(3-5)GlcNAc(2), respectively. Therefore, to determine the microheterogeneity within the remaining glycosylation sites, the glycoprotein was reduced, carboxymethylated, and digested with trypsin. The tryptic fragments were then subjected to concanavalin A (Con A) affinity chromatography, and the material bound by Con A-Sepharose was purified using reverse-phase high-performance liquid chromatography (HPLC). The tandem mass spectrometry (ESI-MS/MS) and the MALDI analysis of the PNGase F-digested glycopeptides indicated that (1) N(692) and N(766) sites from the d-peptide chain both bear glycans consisting of high-mannose (Fuc(0-1)Man(3-7)GlcNAc(2)), hybrid (Fuc(0-1) Gal(0-1)Man(4-5)GlcNAc(4)), and complex (Fuc(0-1)Gal(0-2)Man(3)GlcNAc(4-5)) structures; and (2) the N(367) site, from the b-peptide chain, is glycosylated only with high-mannose structures (Fuc(0-1)Man(3-5)GlcNAc(2)). Taking into consideration the data obtained from the analysis of either the in-gel-released glycans from the abc- and c-peptides or the tryptic glycopeptide containing the N(367) site, the N(133) site, from the a-peptide, was shown to be glycosylated with truncated and high-mannose-type (Fuc(0-1)Man(4-5)GlcNAc(2)), complex-type (Fuc(0-1)Gal(0-1)Man(3)GlcNAc(5)), and hybrid-type (Fuc(0-1)Gal(0-1)Man(5)GlcNAc(4)) glycans.
溶酶体α-甘露糖苷酶是一种具有广泛特异性的外切糖苷酶,参与糖蛋白的有序降解。牛源酶被用作理解先天性溶酶体贮积症α-甘露糖苷贮积症的重要模型。这种约含1000个氨基酸的酶由五条肽链组成,即α至ε肽链,并含有八个N-糖基化位点。c肽链的N(497)糖基化位点在溶酶体α-甘露糖苷酶(LAMANs)中具有进化保守性,对维持该酶的溶酶体稳定性非常重要。在这项工作中,我们依靠基于质谱技术并结合外切糖苷酶消化和化学衍生化的方法,报告牛糖蛋白八个N-糖基化位点中六个位点的N-聚糖的详细结构及其分布。对牛LAMAN经PNGase F释放的聚糖的分析表明,主要结构分为三类,即高甘露糖型(Fuc(0 - 1)Glc(0 - 1)Man(4 - 9)GlcNAc(2))、杂合型(Gal(0 - 1)Man(4 - 5)GlcNAc(4))和复合型(Fuc(0 - 1)Gal(0 - 2)Man(3)GlcNAc(3 - 5))N-聚糖,具有核心岩藻糖基化和平分型GlcNAc。为了研究每个糖基化位点N-聚糖的确切结构,使用SDS-PAGE和凝胶内去糖基化方法分离牛LAMAN的肽链。这些实验表明,来自c肽和ε肽的N(497)和N(930)位点仅含有高甘露糖型聚糖Glc(0 - 1)Man(5 - 9)GlcNAc(2),包括进化保守的Glc(1)Man(9)GlcNAc(及Fuc(0 - 1)Man(3 - 5)GlcNAc(2)。因此,为了确定其余糖基化位点内的微观异质性,对糖蛋白进行还原、羧甲基化并用胰蛋白酶消化。然后将胰蛋白酶片段进行伴刀豆球蛋白A(Con A)亲和色谱,并用反相高效液相色谱(HPLC)纯化与Con A - 琼脂糖结合的物质。对PNGase F消化的糖肽进行串联质谱(ESI-MS/MS)和基质辅助激光解吸电离(MALDI)分析表明:(1)来自d肽链的N(692)和N(766)位点均带有由高甘露糖(Fuc(0 - 1)Man(3 - 7)GlcNAc(2))、杂合型(Fuc(0 - 1)Gal(0 - 1)Man(4 - 5)GlcNAc(4))和复合型(Fuc(0 - 1)Gal(0 - 2)Man(3)GlcNAc(4 - 5))结构组成的聚糖;(2)来自b肽链的N(367)位点仅被高甘露糖结构(Fuc(0 - 1)Man(3 - 5)GlcNAc(2))糖基化。考虑到从abc肽和c肽的凝胶内释放的聚糖分析或含有N(367)位点的胰蛋白酶糖肽分析获得的数据,来自a肽的N(133)位点被截短型和高甘露糖型(Fuc(0 - 1)Man(4 - 5)GlcNAc(2))、复合型(Fuc(0 - 1)Gal(0 - 1)Man(3)GlcNAc(5))和杂合型(Fuc(0 - 1)Gal(0 - 1)Man(5)GlcNAc(4))聚糖糖基化。